CLINICAL_TRIALS
trial_result
· 2022-04-22
Clinical Trial Update: Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow [Phase 2]
Summary
Phase 2 clinical trial update investigating secondary adjuvant treatment for patients with isolated tumor cells in bone marrow in breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oslo University Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED